About Adiana
Adiana is a company based in Marlborough (United States) founded in 1997 was acquired by Cytyc in February 2007. Adiana has raised $23 million across 1 funding round from investors including Boston Scientific, Orbimed and Abingworth. Adiana operates in a competitive market with competitors including Daré Bioscience, Aspivix, Femasys, Uteron Pharma and RemovAid, among others.
- Headquarter Marlborough, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23 M (USD)
in 1 rounds
-
Latest Funding Round
$23 M (USD), Series D
Aug 25, 2005
-
Investors
Boston Scientific
& 9 more
-
Employee Count
Not available
-
Acquired by
Cytyc
(Feb 26, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Adiana
Adiana has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series D round of $23 million completed in August 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Adiana
Adiana has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Orbimed and Abingworth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are made by Tullis Health Investors.
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Early stage venture capital firm investing in the US
|
Locked | Locked | Locked |
Investor details for Adiana
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adiana
Investment portfolio details for Adiana
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Adiana
Detailed financials for Adiana
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adiana Comparisons
Peer comparison for Adiana
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adiana
Adiana operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daré Bioscience, Aspivix, Femasys, Uteron Pharma and RemovAid, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-hormonal pharmaceutical products for female contraceptives are developed.
|
|
| Locked | Locked | Locked |
A next-generation suction-based cervical device for gynecology is provided.
|
|
| Locked | Locked | Locked |
Medical devices for women's healthcare are developed and provided.
|
|
| Locked | Locked | Locked |
Develops products dedicated to female healthcare solutions.
|
|
| Locked | Locked | Locked |
Medical devices for subdermal implant removal are developed.
|
Detailed competitors of Adiana
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adiana
Complete news archive for Adiana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adiana
Adiana was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Adiana is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
Adiana is a funded company, having raised a total of $23M across 1 funding round to date.
The company was founded in 1997 in Marlborough, United States, focusing on medical devices in womens health. A transcervical sterilization system for permanent birth control was developed, incorporating a radiofrequency generator, disposable delivery catheter, and implantable polymer matrix per fallopian tube. FDA approval was received in 2009. Acquisition by Cytyc, now part of Hologic, occurred in February 2007.
Adiana's top competitors include Daré Bioscience, Femasys and Aspivix.
Adiana has 10 investors. Key investors include Boston Scientific, Orbimed, Abingworth, Cytyc, and Tullis Health Investors.